Text Size:
Color Theme:

Company Information

Revenue, expenses and profitability over five years.

Income Statement

BIOGEN PHARMACHEM INDUSTRIES LTD.

NSE Code
-
BSE Code
531752
ISIN
INE703D01023
Industry
Finance & Investments
Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Table can be scrolled horizontally on smaller screens.

Five-year standalone Income Statement for the selected company
ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue1.001.001.001.001.00
INCOME
Revenue From Operations [Net]0.000.000.000.002.47
Total Operating Revenues0.000.000.000.002.47
Other Income2.561.202.380.910.01
Total Revenue2.561.202.380.912.48
EXPENSES
Purchase Of Stock-In Trade0.000.000.000.002.01
Employee Benefit Expenses0.280.170.080.170.05
Other Expenses1.321.320.370.280.42
Total Expenses1.601.490.450.462.49
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax0.96-0.291.930.46-0.01
Profit/Loss Before Tax0.96-0.291.930.46-0.01
Tax Expenses-Continued Operations
Current Tax0.100.000.000.000.00
Total Tax Expenses0.100.000.000.000.00
Profit/Loss After Tax And Before ExtraOrdinary Items0.86-0.291.930.46-0.01
Profit/Loss From Continuing Operations0.86-0.291.930.46-0.01
Profit/Loss For The Period0.86-0.291.930.46-0.01
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)0.010.000.030.010.00
Diluted EPS (Rs.)0.010.000.030.010.00

Source: Financial statements as reported by the company.